Before the Risk of Adhesions MAY BECOME THE REALITY
RISK OF ADHESIONS
Up to 93% of patients have been shown to develop adhesions following laparotomy.2
In a pivotal trial, only 49% of Seprafilm patients developed adhesions versus 94% of untreated patients.2*
*Randomized, double-blinded, multicenter, clinical study involving 183 patients (175 evaluable) with ulcerative colitis and familial polyposis undergoing abdominal surgery.
- Seprafilm® Adhesion Barrier Instructions for Use (IFU); Genzyme Corporation, Cambridge, MA; 2017.
- Becker JM, Dayton MT, Fazio VW, et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg. 1996;183(4):297-306.